Skip to content

Ketamine: all studies

Page 382 of 449: studies 3,811 to 3,820 of 4,483, newest first. Back to the ketamine overview

Research

What Chemsex does to the brain - neural correlates (ERP) regarding decision making, impulsivity and hypersexuality.

European Archives of Psychiatry and Clinical Neuroscience February 1, 2025 Johanna Schwarz, Marcus Gertzen, Andrea Rabenstein et al. 14 citations

Chemsex describes the use of specific substances (methamphetamine, GHB/GBL, mephedrone, ketamine) which initiate or enhance sexual experiences and is mainly prevalent among men who have sex with men. Many Chemsex users experience somatic complications (for example sexually transmitted diseases) and sometimes adverse sociological, psychological, and neurological symptoms, such as depression,...

DOI: 10.1007/s00406-024-01856-2 (opens in new tab) Full text (opens in new tab) Chemsex Executive functions Hypersexuality Inhibition +2

Structural neural plasticity evoked by rapid-acting antidepressant interventions.

Nature Reviews Neuroscience February 1, 2025 Clara Liao, Alisha N Dua, Cassandra Wojtasiewicz et al. 60 citations

A feature in the pathophysiology of major depressive disorder (MDD), a mood disorder, is the impairment of excitatory synapses in the prefrontal cortex. Intriguingly, different types of treatment with fairly rapid antidepressant effects (within days or a few weeks), such as ketamine, electroconvulsive therapy and non-invasive neurostimulation, seem to converge on enhancement of neural...

5-HT1B receptor activation produces rapid antidepressant-like effects in rodents.

Pharmacology, Biochemistry, and Behavior February 1, 2025 Erin A Clark, Lien Wang, Taleen Hanania et al. 5 citations

Ketamine is noted for its rapid onset antidepressant response and effectiveness in patients with treatment resistant depression. While most research has focused on glutamatergic mechanisms, recent studies show that antidepressant-like effects in rodents are dependent upon the serotonergic (5-HT) system and suggest a potential contribution of the 5-HT1B receptor. In this study we utilized...

DOI: 10.1016/j.pbb.2024.173917 (opens in new tab) Full text (opens in new tab) Synaptic plasticity 5-ht1b receptor agonist Lateral habenula circuit Rapid onset +5

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction January 30, 2025 Theodore Piper, Francesca Small, Michael Kelleher et al. 27 citations

Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its quality; and to offer recommendations for...

Dissociative and Deep Sedations Administered by Trained Unsupervised Pediatric Residents in Israeli Emergency Departments.

Annals of emergency medicine January 22, 2025 Neta Cohen, Nitai Levy, Jordanna H. Koppel et al. 2 citations

To cover pediatric emergency physicians' off-hours, third-year pediatric residents in Israel are trained for unsupervised administration of emergency department (ED) dissociative and deep sedation. We assessed the frequency of critical sedation events associated with resident-performed sedations. We conducted a retrospective chart review on all patients receiving intravenous sedation across 10...

DOI: 10.1016/j.annemergmed.2024.12.020 (opens in new tab) Full text (opens in new tab) Deep sedation Dissociative sedation Pediatric residents Pediatric sedation +4

Effects of psychedelics on opioid use disorder: a scoping review of preclinical studies.

Cellular and Molecular Life Sciences January 21, 2025 Alejandra Pulido-Saavedra, Henrique Nunes Pereira Oliva, Tiago Paiva Prudente et al. 5 citations

The current opioid crisis has had an unprecedented public health impact. Approved medications for opioid use disorder (OUD) exist, yet their limitations indicate a need for innovative treatments. Limited preliminary clinical studies suggest specific psychedelics might aid OUD treatment, though most clinical evidence remains observational, with few controlled trials. This review aims to bridge...

DOI: 10.1007/s00018-024-05519-2 (opens in new tab) Full text (opens in new tab) Opioid use disorder Conditioned place preference Self-administration Withdrawal +6

Protocol and Statistical Analysis Plan for the Randomized Trial of Sedative Choice for Intubation (RSI).

medRxiv January 18, 2025 Stephanie C. DeMasi, Brant Imhoff, Ariel A. Lewis et al. preprint

Emergency tracheal intubation is a common and high-risk procedure. Ketamine and etomidate are sedative medicines commonly used to induce anesthesia for emergency tracheal intubation, but whether the induction medication used affects patient outcomes is uncertain. Does the use of ketamine for induction of anesthesia decrease the incidence of death among adults undergoing emergency tracheal...

DOI: 10.1101/2025.01.18.25320768 (opens in new tab) Full text (opens in new tab) Emergency medicine Sedation Intubation Clinical trials +1

Brain structural changes underlying clinical symptom improvement following fast-acting treatments in treatment resistant depression.

Journal of Affective Disorders January 15, 2025 Zhiliang Long, Jiao Li, Marco Marino 7 citations

Electroconvulsive therapy (ECT), ketamine infusion (KI), and total sleep deprivation (TSD) are effective and fast in treating patients with treatment-resistant depression (TRD). However, it remains unclear whether the three treatments have the same effect on clinical symptom improvement and have common brain structural mechanisms. The current study included 127 TRD patients and 37 healthy...

Enhancing proteasome activity by NMDAR antagonists explains their therapeutic effect in neurodegenerative and mental diseases.

Scientific Reports January 13, 2025 Fikret Sahin, Aslihan Gunel, Buse Turegun Atasoy et al. 10 citations

NMDAR antagonists, such as memantine and ketamine, have shown efficacy in treating neurodegenerative diseases and major depression. The mechanism by which these drugs correct the aforementioned diseases is still unknown. Our study reveals that these antagonists significantly enhance 20S proteasome activity, crucial for degrading intrinsically disordered, oxidatively damaged, or misfolded...

DOI: 10.1038/s41598-024-84479-w (opens in new tab) Full text (opens in new tab) Mental diseases N-methyl-d-aspartate receptor nmdar antagonists Neurodegenerative diseases Proteasome +5

Incidence and risk factors of postoperative delirium in elderly surgical patients 2023.

Scientific Reports January 9, 2025 Efrem Fenta, Diriba Teshome, Simegnew Kibret et al. 36 citations

Postoperative delirium has the potential to impact individuals of all age groups, with a significant emphasis on the elderly population. Its presence leads to an increase in surgical morbidity and mortality rates, as well as a notable prolongation of hospital stays. However, there is a lack of research regarding the prevalence, risk factors, and implications of postoperative delirium in...

DOI: 10.1038/s41598-024-84554-2 (opens in new tab) Full text (opens in new tab) Elderly patients Postoperative delirium Geriatric surgery Elderly care +2